Related Experiment Video
Updated: Apr 3, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Apolipoprotein E Mediates Evasion From Hepatitis C Virus Neutralizing Antibodies
Catherine Fauvelle1, Daniel J Felmlee2, Emilie Crouchet1
1Inserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, Strasbourg, France; Université de Strasbourg, Strasbourg, France.
Hepatitis C virus (HCV) uses apolipoprotein E (apoE) to evade antibody neutralization, hindering vaccine development. Reducing apoE exposes viral epitopes, making HCV vulnerable to immune responses.
Area of Science:
- Virology
- Immunology
- Vaccine Development
Background:
- Hepatitis C virus (HCV) vaccine development is challenging due to immune evasion.
- HCV particles associate with lipoproteins, aiding viral entry and immune evasion.
- Mechanisms of HCV lipoprotein-mediated immune evasion are not well understood.
Purpose of the Study:
- To investigate the role of apolipoprotein E (apoE) in HCV immune evasion.
- To determine if apoE shields HCV from antibody neutralization.
- To explore strategies for enhancing HCV vaccine efficacy.
Main Methods:
- Used small interfering RNAs to deplete apolipoprotein E (apoE) in HCV-producing cells.
- Analyzed HCV virions for apoE association with viral envelope glycoprotein E2.
- Tested neutralization of HCV by patient-derived antibodies after apoE depletion.
Main Results:
- HCV-associated apoE enables the virus to evade neutralization by patient-derived antibodies.
- Depletion of apoE exposed conformational epitopes on viral envelope glycoprotein E2.
- The level and conformation of virion-associated apoE influenced antibody neutralization escape.
Conclusions:
- HCV-associated apoE is a key mechanism for immune evasion against patient antibodies.
- Targeting apoE may be a strategy to improve HCV vaccine effectiveness.
- HCV's reliance on apoE for immune evasion presents a significant hurdle for vaccine design.
Related Concept Videos
Hepatitis
Viruses with RNA Genomes
Inhibitors of Viral Protein Synthesis
Hepatic Drug Clearance: Effect of Protein Binding
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Hepatic Drug Excretion: Influencing Factors

